![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Norbrook Laboratories Limited Newry Ie, based in United Kingdom, is a pharmaceutical company.
One of their significant offerings is Meloxicam, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-161 - Rev 01
This Chemical Type CEP, issued on August 01, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2373 associated with this CEP further emphasizes